Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Excerpta Medica BV - Adelphi GroupExcerpta Medica BV - Adelphi Group
VS
Intas PharmaceuticalsIntas Pharmaceuticals
Excerpta Medica BV - Adelphi Group

Excerpta Medica BV - Adelphi Group

Professor W.H. Keesomlaan 4, Amstelveen, 1183 DJ, NL

Last Update: 02/04/2026

View Profile
753/1000Fair

Excerpta Medica is a full-service, global medical communications agency with decades of experience partnering with the healthcare industry. With offices in Amsterdam, London, and Philadelphia, and an extensive network through Omnicom and Adelphi, we can develop innovati...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:196
Subsidiaries:32
12-month incidents
0
Known data breaches
0
Attack type number
0
Intas Pharmaceuticals

Intas Pharmaceuticals

Sarkhej Gandhinagar Highway, Near Sola Bridge, Ahmedabad, Gujarat, IN

Last Update: 01/04/2026

View Profile
Between 750 and 799
https://intaspharma.com
795/1000Fair

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of su...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:18,773
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Excerpta Medica BV - Adelphi Group

Excerpta Medica BV - Adelphi Group

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Intas Pharmaceuticals

Intas Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Excerpta Medica BV - Adelphi Group in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Intas Pharmaceuticals in 2026.

Incidents

Incident History - Excerpta Medica BV - Adelphi Group (X = Date, Y = Severity)

Excerpta Medica BV - Adelphi Group cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Intas Pharmaceuticals (X = Date, Y = Severity)

Intas Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Excerpta Medica BV - Adelphi Group

Excerpta Medica BV - Adelphi Group

Incidents
No explicit notable incidents reported.
Intas Pharmaceuticals

Intas Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one has experienced at least one data breach ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one holds the most compliance certifications ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one has the most subsidiaries ?
Between Excerpta Medica BV - Adelphi Group company and Intas Pharmaceuticals company, which one has the largest number of employees ?
Between Excerpta Medica BV - Adelphi Group and Intas Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Excerpta Medica BV - Adelphi Group and Intas Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Excerpta Medica BV - Adelphi Group or Intas Pharmaceuticals ?
Which company is PCI DSS compliant - Excerpta Medica BV - Adelphi Group or Intas Pharmaceuticals ?
Between Excerpta Medica BV - Adelphi Group and Intas Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Excerpta Medica BV - Adelphi Group and Intas Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-44541
SUMMARY

Fides is an open-source privacy engineering platform. From version 2.33.0 to before version 2.84.5, there is a DOM-based XSS vulnerability in fides.js via the fides_description override. This issue has been patched in version 2.84.5.

PUBLISHED
Date2026-06-08
UPDATED
Date2026-06-08
RISK INFORMATION (Score: )
CVSS4
Base Score: 7.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-49141
SUMMARY

WACRM prior to commit 73041bf contain an authorization bypass vulnerability in the automation engine that allows authenticated attackers to access and modify contacts belonging to other tenants by supplying an arbitrary caller-controlled contact_id in the POST request body without tenant ownership verification. Attackers can exploit the service-role client that bypasses row-level security to modify victim contact fields including name, email, and company across tenant boundaries using only a known contact UUID.

PUBLISHED
Date2026-06-08
UPDATED
Date2026-06-08
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:H/A:N
CVSS4
Base Score: 5.1
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4.7
EXPLOITABILITY
1.8
CVE-2026-47345
SUMMARY

Namespace attributes are not encoded correctly during HTML serialization. This allows bypassing the cross-site scripting prevention mechanism of typo3/html-sanitizer before version 2.3.2.

PUBLISHED
Date2026-06-08
UPDATED
Date2026-06-08
RISK INFORMATION (Score: )
CVSS4
Base Score: 5.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-47344
SUMMARY

When ALLOW_INSECURE_RAW_TEXT is enabled, whitespace-variant closing tags (e.g., </style\t>) are not recognized by the sanitizer but accepted by browsers as valid end tags, allowing subsequent content to escape sanitization. This allows bypassing the cross-site scripting prevention mechanism of typo3/html-sanitizer before version 2.3.2.

PUBLISHED
Date2026-06-08
UPDATED
Date2026-06-08
RISK INFORMATION (Score: )
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-46484
SUMMARY

Headplane is a feature-complete Web UI for Headscale. Prior to versions 0.6.3 and 0.7.0-beta.3, Headplane was vulnerable to a path traversal / authorization bypass in the Headscale API client used by node and user rename operations. This issue has been patched in versions 0.6.3 and 0.7.0-beta.3.

PUBLISHED
Date2026-06-08
UPDATED
Date2026-06-08
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
IMPACT SCORE
5.2
EXPLOITABILITY
2.8